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ABSTRACT
In the last years, the prevalence of HPV infection in the anal region has increased, especially in some 
groups like homosexual and HIV-positive people. Since this infection can be associated with the 
development of squamous anal cancer due to its progression from HPV infection to anal intraepi-
thelial neoplasia (AIN) and finally to cancer, the screening and evaluation of these conditions are 
important. Anal cytology and high resolution anoscopy are good methods that are available and can 
be used. Although useful, these methods should be performed correctly and not indiscriminately in 
all patients. Patients for whom anal cytology screening is recommended are: HIV-infected patients, 
homosexuals, women who present with high-grade vulvar squamous intraepithelial neoplasia, vul-
var cancer or cervical cancer. An abnormal anal cytology should be further evaluated with high 
resolution anoscopy.
Keywords: anal canal; papillomavirus infections; cell biology; carcinoma in situ.
identify these pre-invasive lesions is being ques-
tioned. Such questions relate to the groups to be 
screened and the best way to implement it such 
screening. The purpose of this study was to re-
view the literature about the use of anal cytology 
and anoscopy to screening and evaluation of anal 
intraepithelial neoplasia. 
ANAL CYTOLOGY
Anal cytology is a noninvasive method of screen-
ing, which is performed primarily by anal secre-
tion collection through a brush (Dacron swab) 
introduced into the anal canal and removed with 
gentle rotation movements. It is indicated to 
avoid anal sex and douching in the day before the 
procedure, since these practices can decrease cel-
lular recovery. Special caution should be taken for 
not touching anal canal warts and rectum walls 
with the brush to avoid any fecal contamination. 
It is controversial how deep the swab must be in-
troduced in the anal canal; however, the introduc-
tion of 4 cm from the anal margin seems to be 
more effective.6 The collected material should be 
smeared on glass microscope slides and immedi-
ately fixed with ethanol. Another possibility is the 
liquid-based cytology by submerging the material 
obtained in a small glass containing preservative 
fluid. This method, when available, is preferable 
INTRODUCTION 
The association between human papillomavirus 
(HPV) and squamous anal carcinoma has been 
strongly demonstrated in the last years. Studies 
have shown that this association is true in about 
93% of the cases. HPV infection in the anal region, 
therefore, has a great impact on the development 
of cancer. Only HPV in the cervix is described to 
have a greater impact on the development of can-
cer; actually cervical cancer is close to 100% as-
sociated with HPV.1 Studies have show that about 
2,000 new cases of HPV-associated anal cancers 
are diagnosed each year in the United States.2 
Similarly to what happens in uterine cervix, 
anal carcinoma is preceded by cellular abnormal-
ities or intraepithelial neoplasias, and these also 
progress from low-grade lesions to high-grade 
lesions and finally, depending on some circum-
stances, to cancer. However, the percentage of 
regression and progression of the lesions in these 
patients is unclear.3,4 The HPV types implicated in 
anal intraepithelial neoplasia are similar to those 
described for the cervix, and it is not infrequent to 
observe infection by multiple types.5
Since the prevalence of anal cancer has been 
increasing and the precursor conditions can be 
detected by screening methods, the relevance of 
using anal cytology and anoscopy as methods to 
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as it leads lower rates of unsatisfactory slides.7 The sample is 
then processed and analyzed by Papanicolaou methodology 
and hematoxylin-eosin staining. The appropriate terminolo- 
gy to report the results should be the one suggested by Bethesda 
criteria, which is shown in Box 1.8
Self-collecting of anal cytology samples is an option that 
can also be used. Apparently, it presents a sensitivity similar to 
other collection methods.9 As more studies confirm this similar 
efficacy, this kind of collection will probably increase. 
the anal canal and perianal area by devices that allow image 
magnification in order to detect colposcopic lesions. It can be 
performed with a colposcope or a magnifying glass. The col-
poscope allows a magnificaton of 8 to 20 times, whereas with 
the magnifying glass it can reach 10 times. Therefore, there is 
no preference on using one of the other available device. In 
case the health unit where HIV patients are seen do not have 
a colposcope, examination with a magnifying glass can be an 
affordable option. However, the physician experience to exam 
this region is an paramount importance. 
High resolution anoscopy should mainly assess the anal 
transition zone, in which the columnar epithelium of the rec-
tum and the squamous epithelium of the anal canal are adjacent 
and where the process of epithelial metaplasia occurs. It is nec-
essary to keep away the anal folds before initiating the anoscopy 
(Figures 1 and 2).
Box 1: Description of anal cytology terminology
Unsatisfactory	due	to	inadequate	cellularity
Negative for intraepithelial lesion or malignancy
Atypical	squamous	cells	of	undetermined	significance	
(ASCUS)
Low-grade	squamous	intraepithelial	lesions	(LSIL)
High-grade	squamous	intraepithelial	lesions	(HSIL)
There are few studies comparing anal cytology efficacy in 
detecting intraepithelial lesions with other methods such anos-
copy and histology. Nahas et al.10 demonstrated that consider-
ing histology as the gold-standard anal cytology had a sensitiv-
ity of 61% and 60% specificity for detecting anal intraepithelial 
neoplasia (AIN) of any degree. Concerning high-grade AIN, 
the sensitivity and specificity were, respectively, 16% and 97%, 
concluding that anal cytology is not sensitive enough to rule 
out anal dysplasia and should therefore be complemented by 
high-resolution anoscopy. Santoso et al.11 found a 5.9% preva-
lence of cytological changes in women with genital intraepithe-
lial neoplasia, compared to 38% of women with abnormalities 
at anoscopy and 12.5% of biopsy-proven anal intraepithelial 
neoplasia. These data show a sensitivity and specificity of anal 
cytology around 8% and 94%, respectively. This low sensitiv-
ity, however, has not been observed in other studies: Fox,12 
when comparing anal cytology and anoscopy findings, found 
a sensitivity of 83% and a specificity of 38% for anal cytology, 
indicating that cytology is a useful screening method for high-
risk patients. It is believed that the improvement of cytology 
techniques in the last years contributed to better sensitivity 
of the method, which in general varies from 50 to 90%. In 
HIV-infected patients it can reach more than 80%.13,14 Analysis 
of anal cytology sensitivity in relation to other methods should 
define what is considered as abnormal anal cytology. Greater 
sensitivity and lower specificity is observed when features sug-
gestive HPV alone are characterized as abnormal cytology, as 
opposed to anal intraepithelial neoplasia.15
HIGH RESOLUTION ANOSCOPY 
High resolution anoscopy (HRA) is a complementary method 
that can be used in association with anal cytology for detect-
ing anal abnormalities. This procedure consists in visualizing 
Figure 1: Anal transition zone (Adapted from Medical Images 
site: http://doctorsgates.blogspot.com).
Figure 2: Folds separation before anoscopy. Patient 
presenting AIN II lesions (collection of Infectious Diseases 
in Gynecology and Obstetrics Sector Department of ObGyn/
Genital Lesions Ambulatory - DTG/HC-UFPR).
HPV and precursors of cancer in the anal region: what should be known for diagnosis?
Internal hemorrhoidal plexus
Internal anal esphincter
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Anorectal junction
Columns of Morgagni
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A gauze pad soaked in 3% acetic acid and wrapped 
around a q-tip is inserted in the anal canal prior to visu-
alization and, the acetowhite areas are looked for, similarly 
to what is observed in cervical colposcopy.5 HRA allows the 
clinician to obtain biopsy specimens of the lesions for his-
topathologic evaluation. Thereby, hyper-keratotic plaques 
and pigmented or grayish areas must be biopsied (Figures 3 
and 4).9 Also, extensive warts as showed in Figure 5 should 
be biopsied, since a histological definition is needed before 
management of the lesions.
HRA sensitivity in detecting anal intraepithelial neopla-
sia among different high-risk populations has been demon-
strated to be about 69 to 93%, with a specificity ranging from 
32 to 64%.16 An important limitation of this method refers 
to its dependence on the operator’s ability to visualize and 
biopsy the abnormalities.17
Some authors consider HRA as a complementary screen-
ing test for high-risk patients.10 However, there is a tendency 
to keep HRA as a complementary method to evaluate pa-
tients with abnormal anal cytology, since HRA is cheaper 
and less available than the cytology. Nonetheless, when 
available, it can also be used as a screening procedure, which 
increases the sensitivity for identification of anal intraepi-
thelial neoplasia.18
RISK FACTORS IMPLICATED IN ANAL  
INTRAEPITHELIAL NEOPLASIA
The incidence of anal cancer has increased in some specific 
groups and not homogenously in the population. Thereby, 
findings of anal intraepithelial neoplasia tend to be more fre-
quent in these particular groups. 
Figure 3: Pigmented area and acetowhite area (collection of 
Infectious	Diseases	in	Gynecology	and	Obstetrics	Sector	–	 
Department of ObGyn/Genital Lesions Ambulatory- 
DTG/HC-UFPR).
Figure 4: Patient with vulvar intraepithelial neoplasia (VIN) 
III and anal intraepithelial neoplasia (collection of Infectious 
Diseases	 in	Gynecology	and	Obstetrics	Sector	–	Department	
of ObGyn/Genital Lesions Ambulatory- DTG/HC-UFPR).
Figure 5: Extensive condylomas in vulvar and perianal 
regions (collection of Infections Diseases in Gynecology and 
Obstetrics	 Sector	 –	 Department	 of	 ObGyn/Genital	 Lesions	
Ambulatory- DTG/HC-UFPR).
Carvalho, Ferreira, Bueno
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Several studies were conducted in order to identify 
risk factors for developing anal intraepithelial neoplasia 
and abnormal anal cytology.
It is well established that HIV-infected patients and 
men that have sex with men (MSM) who practice anal 
sex are at higher risk of developing AIN, as well as im-
munocompromised patients and people with warty le-
sions above the pectinate line.19,20
In the heterosexual female population, however, the 
issue is more divergent. Anal intercourse has been pro-
posed as an important risk factor in some studies.21,22 
Nevertheless, Park et al.23 did not find a significant as-
sociation between HPV infection, abnormalities at anal 
cytology and anal sex practices. As a caveat, this was a 
small study with 92 women with only nine presenting 
abnormal anal cytology.
Regarding the association of cervical lesions and anal le-
sions in women, an important correlation is also suggested. 
In women presenting cervical intraepithelial neoplasia, the 
percentage of alterations varies from 9 to 29%. On the other 
hand, in women with normal cervical cytology, this percent-
age decreases to less than 5%. Recently, in spite of the small 
sample, a study in Brazil showed that among 40 women with 
cervical lesions, seven presented alterations in anal cytology, 
in contrast to only one among 40 control women.24 Another 
study demonstrated that of 211 women with cervical intraepi-
thelial neoplasia, abnormal anal cytology were found in 19.5% 
of them, in contrast to only 2.5% in the control group of 80 
women. High-grade lesions in the cervix appear to be a risk 
factor for AIN, as compared to low-grade lesions.10,21,25 
It is suggested that women with vulvar lesions related 
to cervical alterations are at a greater risk of presenting 
abnormal anal cytology, when compared to women with 
isolated cervical alterations.23
HIV-infected women have a higher frequency of ab-
normal anal cytology in relation to seronegative women, 
with abnormal cytology in up to 26% of cases. Hes-
sol et al.26 compared 470 HIV-infected women to 185 
HIV-negative women. Abnormal cytology was found in 
21% of the HIV-infected group compared to 6% in the 
control group. This higher frequency of abnormal find-
ings is also related to the concomitant presence of altered 
cervical cytology and lower levels of CD4 counts.27,28
CONCLUSIONS
Anal cytology is a useful method for screening anal in-
traepithelial lesions. However, it is indicated only for 
specific populations who are at high-risk of anal pre-
cancerous lesions and, thus, who will likely benefit from 
this technique. 
It is already well-defined that MSM and HIV-infected 
patients, both men and women, should be screened for 
anal cytology. Additionally, women who present high-
grade vulvar squamous intraepithelial neoplasia, vulvar 
cancer or cervical cancer must be part of this group, 
which corresponds to the absolute indications for anal 
cytology (Box 2).
Some other indications for anal cytology are still con-
troversial. It is not clear about the real need and accu-
racy of anal cytology in those situations. As part of this 
group, relative indications for anal cytology could be: 
women presenting high-grade cervical intraepithelial 
neoplasia, women with visible lesions in perianal region 
such as warts, patients that present anal symptomatol-
ogy (pain, bleeding, itch, irritation, discharge, tenesmus 
etc.) and women who practice anal sex (Box 3).
If any abnormality is found at anal cytology, it is 
recommended referral to high resolution anoscopy and 
biopsy of the atypical areas when present.10,12,15 A new 
anoscopy six months thereafter is indicated for patients 
with positive findings.12 In cases of initial negative cy-
tology, this procedure should be repeated in order to de-
crease the possibility of false-negative results.
There is not a guideline concerning routine anal cy-
tology for high-risk patients. Goldie et al.29 concluded 
that annual or biannual anal cytology, regardless of 
when it is started, is comparable to some preventive 
measures accepted in public health.
Anal cytology, therefore, consists in a simple and 
minimally invasive procedure, and it is not difficult to 
implement as a routine exam in patients at high risk for 
AIN. In this group of patients, an abnormal anal cytol-
ogy and complementary evaluation with high resolution 
anoscopy can effectively diagnose cancer precursor con-
ditions, directing specific treatment, and thus prevent-
ing the progression of these lesions, with a significant 
decrease in morbidity and mortality of the patients.
Box 2: Absolute indications for AIN screening
Box 3: Relative indications for AIN screening
HIV-infected patients
MSM (men who have sex with men)
Women with high-grade vulvar intraepithelial lesion, 
vulvar cancer or cervical cancer 
Women with high-grade cervical intraepithelial lesion
Anal symptomatology
Women who practice anal sex
Visible lesions in perianal region
HPV and precursors of cancer in the anal region: what should be known for diagnosis?
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